BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 26156090)

  • 1. New Insight into Mucinous Ovarian Cancer.
    Cancer Discov; 2015 Sep; 5(9):900. PubMed ID: 26156090
    [No Abstract]   [Full Text] [Related]  

  • 2. The different etiologies of mucinous and nonmucinous epithelial ovarian cancers.
    Purdie DM; Webb PM; Siskind V; Bain CJ; Green AC
    Gynecol Oncol; 2003 Jan; 88(1 Pt 2):S145-8. PubMed ID: 12586107
    [No Abstract]   [Full Text] [Related]  

  • 3. [A proposed model of ovarian tumorigenesis and a new theory on the origin of ovarian cancer].
    Kong BH; Zheng WX
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):721-3. PubMed ID: 22321342
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent Insights into Mucinous Ovarian Carcinoma.
    Ricci F; Affatato R; Carrassa L; Damia G
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29795040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors in ovarian cancer of epithelial origin by pathological diagnosis.
    Koch M
    Br J Cancer; 1989 Feb; 59(2):257-8. PubMed ID: 2539175
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of cigarette smoking with the risk of ovarian cancer.
    Pan SY; Ugnat AM; Mao Y; Wen SW; Johnson KC;
    Int J Cancer; 2004 Aug; 111(1):124-30. PubMed ID: 15185353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian Mucinous Carcinoma in a Pediatric Patient With Maroteaux-Lamy Syndrome.
    Yazal Erdem A; Özyörük D
    J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1128-e1131. PubMed ID: 34001794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference in subcellular localization of maspin expression in ovarian mucinous borderline tumour.
    Tsuji T; Togami S; Douchi T; Umekita Y
    Histopathology; 2009 Jul; 55(1):130-2. PubMed ID: 19614779
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?
    Jordan SJ; Green AC; Whiteman DC; Webb PM;
    Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Müllerian mucinous borderline tumors.
    Rutgers JK
    Hum Pathol; 2010 Jan; 41(1):151; author reply 151-2. PubMed ID: 19854468
    [No Abstract]   [Full Text] [Related]  

  • 11. Differentiation of various mucinous carcinomas.
    Heatley MK
    Histopathology; 2004 Jul; 45(1):87-8. PubMed ID: 15228449
    [No Abstract]   [Full Text] [Related]  

  • 12. Composite mucinous and granulosa cell tumor of the ovary.
    Kushida Y; Haba R; Kadota K; Doi T; Ishikawa M; Hirakawa E; Kira M
    Pathol Int; 2005 Dec; 55(12):797-801. PubMed ID: 16287496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estrogen synthesis in adenocarcinoma cells of the ovary].
    Yamagata S; Yamamoto K; Matsumoto Y; Kawamura N; Tamura K; Sugawa T
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Dec; 42(12):1703-4. PubMed ID: 2177491
    [No Abstract]   [Full Text] [Related]  

  • 14. Ovarian endocrine activity in association with hormonally inactive neoplasia.
    Scott JS; Lumsden CE; Levell MJ
    Am J Obstet Gynecol; 1967 Jan; 97(2):161-70. PubMed ID: 4289301
    [No Abstract]   [Full Text] [Related]  

  • 15. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
    McKenney JK; Soslow RA; Longacre TA
    Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of CEACAM6 in borderline and invasive mucinous ovarian neoplasms.
    Litkouhi B; Litkouhi B; Fleming E; Welch WR; Berkowitz RS; Birrer MJ; Mok SC
    Gynecol Oncol; 2008 May; 109(2):234-9. PubMed ID: 18331757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P53 and Ki67 immunoexpression in mucinous malignant ovarian tumors.
    Kamal CK; Simionescu CE; Mărgăritescu C; Stepan A
    Rom J Morphol Embryol; 2012; 53(3 Suppl):799-803. PubMed ID: 23188443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histochemical analysis of estrogen and progesterone receptors and gastric-type mucin in mucinous ovarian tumors with reference to their pathogenesis.
    Shiohara S; Shiozawa T; Shimizu M; Toki T; Ishii K; Nikaido T; Fujii S
    Cancer; 1997 Sep; 80(5):908-16. PubMed ID: 9307191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of octamer-4 in serous and mucinous ovarian carcinoma.
    Zhang J; Li YL; Zhou CY; Hu YT; Chen HZ
    J Clin Pathol; 2010 Oct; 63(10):879-83. PubMed ID: 20876318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunophenotype and K-RAS mutation in mucinous ovarian adenocarcinoma with mural nodule of high-grade sarcoma: case report.
    Desouki MM; Fadare O; Kanbour A; Kanbour-Shakir A
    Int J Gynecol Pathol; 2014 Mar; 33(2):186-90. PubMed ID: 24487474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.